Medasense-AMAR-approved

Receipt of Israeli AMAR

26 Jul 2017 News and Events

We are pleased to share with you the exciting news that Medasense has received AMAR approval to sell our pain (Nociception) monitoring system in Israel!
Israeli anesthesiologists are now able to join their European colleagues, who are already using our technology , to optimize and personalize the intraoperative analgesic administration.

This is a significant milestone for Medasense. We are very proud to enter our home market, where our technology was developed!

Medasense-IPT-ONLINE

Does that hurt??

19 Jul 2017 News and Events

Medasense featured in Innovations in Pharmaceutical Technology publication.
Read our article written by CEO, Galit Zuckerman-Stark, to learn how an objective approach could help healthcare professionals better assess pain.

To read the full article click here.

The article is taken from Innovations in Pharmaceutical Technology, July 2017, pages 15-17. © Samedan Ltd

 

 

Medasense headlines Anesthesiology News publication - 13 Feb. 2017

Article in Anesthesiology News

16 Feb 2017 News and Events

Medasense headlines “Anesthesiology News” – the most-read publication by anesthesiologists in the USA

The article reports on clinical trial results previously published in Anesthesiology in 2016, with insightful interviews from lead investigators, Dr. Daniel Sessler (Head of Center of Outcomes Research, Cleveland Clinic, Ohio, USA) and Dr. Ruth Edry (Department of Anesthesiology, Rambam Medical Centre, Haifa, Israel).

Read More
Medasense Launches New Pain Monitoring Device, PMD200 following European CE approval - January 2017

PMD-200 CE Approval

18 Jan 2017 News and Events

Medasense Launches New Pain Monitoring Device, PMD200™ following European CE approval

Medasense Biometrics Ltd. announced today that it has received CE mark approval for its novel Pain Monitoring Device, PMD200. This new technology is now available to help physicians objectively assess a patient’s pain in critical care situations, where

Read More
1 2 3 4

Search

+